866-997-4948(US-Canada Toll Free)

Global castration resistant prostate cancer treatment market 2017-2021

Published By :


Published Date : Jul 2017

Category :


No. of Pages : 87 Pages

About Castration-Resistant Prostate Cancer (CRPC) Treatment

Prostate cancer is also known as carcinoma of the prostate is cancer of the prostate gland that affects only the male population. It is a slow progressive disease. CRPC is an inveterate stage of prostate cancer, in which almost 90% of individuals develop metastases, specifically in the skeleton. The major therapies involved in the treatment of CRPC are hormonal therapy and chemotherapy.

Technavios analysts forecast the global castration-resistant prostate cancer treatment market to grow at a CAGR of 9.01% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global castration resistant prostate cancer treatment market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

Technavio's report, Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Astellas Pharma
Johnson & Johnson

Other prominent vendors
Active Biotech
ANI Pharmaceuticals
Bavarian Nordic
Bristol-Myers Squibb
Innocrin Pharmaceutical
Myovant Sciences
Northwest Biotherapeutics
OncoGenex Pharmaceuticals
Oncolytics Biotech
Madrigal Pharmaceuticals)
Takeda Pharmaceutical
Teva Pharmaceutical Industries

Market driver
Physicians preference toward hormonal therapy
For a full, detailed list, view our report

Market challenge
High cost of treatment
For a full, detailed list, view our report

Market trend
Increasing consolidation in cancer treatment market
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
Market outline
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Pipeline landscape
PART 07: Market segmentation by therapy
Hormonal therapy
PART 08: Geographical segmentation
CRPC treatment market in Americas
CRPC treatment market in EMEA
CRPC market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
Market drivers
Market challenges
PART 11: Market trends
Increasing consolidation in cancer treatment market
Emergence of targeted therapies and immunotherapies
PART 12: Vendor landscape
Competitive landscape
PART 13: Key vendor analysis
Astellas Pharma
Johnson & Johnson
Other prominent vendors
PART 14: Appendix
List of abbreviations

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *